# Hydrogen, COVID-19 and getting back into shape after infection

> China's 2020 recommendations, hospital studies with a hydrogen-oxygen mixture, and studies in recovery and long COVID: results and numbers.

URL: https://pragmah2.com/en/knowledge-base/covid/
Updated: 2026-11-20

[Hydrogen and health](https://pragmah2.com/en/hydrogen-and-health/) / [Research review](https://pragmah2.com/en/knowledge-base/)

In March 2020 China's health commission permitted the inhalation of a mixture of 66.6% hydrogen and 33.3% oxygen in the treatment of COVID-19. In a hospital study, participants felt relief from breathlessness sooner, and during recovery they covered 64 m more in the walk test than the placebo group.

Covers

- COVID-19
- long COVID
- breathlessness
- recovery after infection

Studies

Human studies: 7 studies in the cards below, including 2 randomised.

How hydrogen was given

Inhalation, hydrogen water.

On this page

- Key points
- From recommendations to studies
- Studies with a control group
- Recovery and long COVID
- Studies
- Topics
- Questions

## COVID-19: key findings from the studies

- China included the hydrogen-oxygen mixture in its national COVID-19 protocol (7th edition, 2020).
- Multicentre study (90 people): earlier improvement in breathlessness and disease severity than with standard oxygen therapy.
- Recovery (50 people, 14 days of inhalation): walking distance 64 m longer and greater vital capacity of the lungs than after placebo.

## Hydrogen and COVID-19: from Chinese recommendations to studies

The seventh version of the Chinese protocol for the diagnosis and treatment of COVID-19 permitted the use of a hydrogen-oxygen mixture where it is available1. Clinical data appeared in the following months; scientific commentaries had pointed out the need for them2.

The first data came from an open-label multicentre study: 44 participants breathed a hydrogen-oxygen mixture and 46 received standard oxygen therapy3. The authors described earlier improvement in breathlessness and disease severity. It was an open-label study: doctors decided on allocation to the groups.

## Hydrogen inhalation in COVID-19: studies with a control group

A retrospective analysis with matched groups showed a shorter hospital stay: a median of 12 versus 13 days4.

## Hydrogen, long COVID and recovery after infection

In a single-blind trial, 50 people 21–33 days after a positive test breathed hydrogen or placebo twice a day for 60 minutes over 14 days5. The advantage over placebo was 64 m in the 6-minute walk test and 0.19 l of forced vital capacity. In a pilot study with hydrogen water in 32 people with long COVID, fatigue decreased and the walk test improved6.

## Hydrogen and COVID-19: the studies we refer to

Click an entry to see who took part in the study, how hydrogen was given and what the result was.

What the studies say

Selected scientific publications on molecular hydrogen in humans: a description of each study, its results and a link to the source.

**1 COVID-19, a discussion of the guidelines review inhalation 2020**

- **Protocol**: A discussion of the seventh version of the Chinese protocol for the diagnosis and treatment of COVID-19 (March 2020)
- **Result**: The protocol permits breathing a mixture of 66.6% hydrogen and 33.3% oxygen where it is available.
- **Study context**: Discussion of guidelines.

Zhao JY i wsp.. *Interpretations of "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)"*. Chinese Medical Journal, 2020. 2020. [PubMed 32301757](https://pubmed.ncbi.nlm.nih.gov/32301757/) · [Full text](https://pmc.ncbi.nlm.nih.gov/articles/PMC7289291/)

**2 COVID-19, a commentary on the recommendations review inhalation 2020**

- **Protocol**: A commentary on the Chinese recommendations permitting a mixture of 66.6% H2 and 33.3% O2 as part of oxygen therapy in COVID-19
- **Result**: The author notes the inclusion of the hydrogen-oxygen mixture in official recommendations in China.
- **Study context**: Letter to the editor.

Ostojic SM. *COVID-19 and molecular hydrogen inhalation*. Therapeutic Advances in Respiratory Disease 14: 1753466620951051. 2020. [Source](https://pmc.ncbi.nlm.nih.gov/articles/PMC7459175/) · [DOI](https://doi.org/10.1177/1753466620951051)

**3 COVID-19 controlled study inhalation 2020**

- **Participants**: 90 people, 44 H2/O2 and 46 control
- **Protocol**: Standard treatment with added H2/O2 was compared with treatment with oxygen therapy alone. Disease severity, breathlessness, other symptoms and saturation were assessed.
- **Result**: The authors described earlier improvement in some symptoms and in the disease severity scale in the H2/O2 group.
- **Study context**: Multicentre open-label study without randomisation.

Guan WJ i wsp.. *Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial*. Journal of thoracic disease. 2020;12(6):3448-3452. 2020. [PubMed 32642277](https://pubmed.ncbi.nlm.nih.gov/32642277/) · [DOI](https://doi.org/10.21037/jtd-2020-057) · [Full text](https://pmc.ncbi.nlm.nih.gov/articles/PMC7330772/)

**4 Length of hospital stay for COVID-19 observational study n = 88 inhalation 2023**

- **Participants**: 180 people in the database; after matching, 33 H2 and 55 control
- **Protocol**: H2/O2 vs oxygen, plus routine treatment
- **Result**: Median stay 12 vs 13 days; HR for discharge 1.91 (95% CI 1.25–2.92). Discharge by day 21: 93.9% vs 74.5%.
- **Study context**: Retrospective controlled study, PSM. Participants: 88.

Zeng Y i wsp.. *Effect of hydrogen/oxygen therapy for ordinary COVID-19 patients: a propensity-score matched case-control study*. BMC infectious diseases 23(1): 440. 2023. [PubMed 37386364](https://pubmed.ncbi.nlm.nih.gov/37386364/) · [DOI](https://doi.org/10.1186/s12879-023-08424-4) · [Full text](https://pmc.ncbi.nlm.nih.gov/articles/PMC10308743/)

**5 Early rehabilitation after COVID-19 randomised trial n = 50 inhalation 2022**

- **Participants**: 26 men, 24 women; 21–33 days after a positive PCR test
- **Protocol**: 2×60 min/day for 14 days vs placebo
- **Result**: Advantage over placebo: 6-minute walk distance +64±39 m, FVC +0.19±0.24 l and FEV₁ +0.11±0.28 l (all p≤0.025).
- **Study context**: RCT, single-blind. Participants: 50.

Botek M i wsp.. *Molecular Hydrogen Positively Affects Physical and Respiratory Function in Acute Post-COVID-19 Patients: A New Perspective in Rehabilitation*. International journal of environmental research and public health 19(4): 1992. 2022. [PubMed 35206179](https://pubmed.ncbi.nlm.nih.gov/35206179/) · [DOI](https://doi.org/10.3390/ijerph19041992) · [Full text](https://pmc.ncbi.nlm.nih.gov/articles/PMC8872486/)

**6 Fatigue in long COVID Hydrogen water randomised trial n = 32 2024**

- **Participants**: 16 H2 and 16 placebo
- **Protocol**: H2 water for 14 consecutive days
- **Result**: Less fatigue on the FSS (p=0.046; d=0.696), a better 6-minute walk (d=1.010) and chair-stand test (d=1.190).
- **Study context**: Pilot RCT, single-blind. Participants: 32.

Tan Y i wsp.. *The Effect of 14-Day Consumption of Hydrogen-Rich Water Alleviates Fatigue but Does Not Ameliorate Dyspnea in Long-COVID Patients: A Pilot, Single-Blind, and Randomized, Controlled Trial*. Nutrients 16(10): 1529. 2024. [PubMed 38794767](https://pubmed.ncbi.nlm.nih.gov/38794767/) · [DOI](https://doi.org/10.3390/nu16101529) · [Full text](https://pmc.ncbi.nlm.nih.gov/articles/PMC11123997/)

**7 COVID-19: management review inhalation 2020**

- **Participants**: No new study cohort
- **Protocol**: The article discusses early management strategies during the pandemic and potential interventions, including a hydrogen-oxygen mixture.
- **Result**: It does not present a new randomised trial of the efficacy of inhalation.
- **Study context**: Editorial and discussion of strategy.

Guan WJ i wsp.. *Strategies for the prevention and management of coronavirus disease 2019*. The European respiratory journal. 2020;55(4):2000597. 2020. [PubMed 32217658](https://pubmed.ncbi.nlm.nih.gov/32217658/) · [DOI](https://doi.org/10.1183/13993003.00597-2020) · [Full text](https://pmc.ncbi.nlm.nih.gov/articles/PMC7098484/)

Educational information, not medical advice. Full database of publications: [Hydrogen Studies](https://hydrogenstudies.com/dataset).

## COVID-19: topics in this area

[Fatigue](https://pragmah2.com/en/hydrogen-and-health/fatigue/) [Pneumonia](https://pragmah2.com/en/hydrogen-and-health/pneumonia/) [Viral infections](https://pragmah2.com/en/hydrogen-and-health/viral-infections/) [All topics (170)](https://pragmah2.com/en/hydrogen-and-health/)

## COVID-19 and hydrogen: frequently asked questions

**How was hydrogen given in the COVID-19 studies?**

In hospitals, a mixture of 66.6% hydrogen and 33.3% oxygen was used as an addition to standard care. During recovery, participants inhaled hydrogen twice a day for 60 minutes over 14 days, and in the pilot study in people with long COVID they drank hydrogen water for 14 days.

**What did the study of recovery after COVID-19 show?**

In a single-blind study of 50 people, after 14 days of inhalation the hydrogen group walked 64 m further in the 6-minute walk test than the placebo group and had a forced vital capacity 0.19 l higher.

**Is it a medical device?**

No. PRAGMA HYDROGEN is a device for wellness use. It does not replace a consultation with a doctor.

**Is hydrogen inhalation safe?**

In clinical trials, hydrogen inhalation was well tolerated. The generator has 8 safety features that stop it working if a fault occurs. Hydrogen is a flammable gas: do not smoke or use an open flame near the device. People with chronic conditions, pregnant women and children should consult a doctor before use.

## See also

[Asthma, allergy and sinuses](https://pragmah2.com/en/knowledge-base/asthma-allergies/) [Smog, pneumoconiosis and interstitial lung disease](https://pragmah2.com/en/knowledge-base/smog-silicosis/) [COPD and chronic lung diseases](https://pragmah2.com/en/knowledge-base/copd/)

### Sources and method

Every study we describe links to its publication. See how we read studies and how we assess the strength of the evidence.

[How we read studies](https://pragmah2.com/en/knowledge-base/how-to-read-the-studies/) [Study bank](https://pragmah2.com/en/studies/)

### Any questions?

Call or write to us. We reply within one working day.

[Contact](https://pragmah2.com/en/contact/)
